Clarepharm Limited
- Active
- Small
- Holding
- 31 years
- 37 employees
- £923,862 (cur assets)
- 1m-15m
- Virtual address
- 3 directors
- 1 owner
- London
Two conditions of three:
1.Turnover < £10.2 million
2.Balance sheet total < £5.1 million
3.Average number of employees < 50
Field of Operation
Summary
Clarepharm Limited is a private limited company registered in England/Wales with the registration number 02940027. The company was founded thirty one years ago on June 17, 1994, and registered at W1U 7BU, United Kingdom, London, Fifth Floor Watson House, 54-60 Baker Street. The address is probably virtual as 294 companies are registered at the same address. Its status is active. The company operates in the retail, the pharmacy industries. Officially, it has one owner or PSCs, three directors, and thirty seven employees.
It's a small company as it met two conditions of three: turnover less than £10.2 million, balance sheet less than £5.1 million, employees less than 50. The last reported current assets is £923,862.
WARNING: The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.
Owners & PSC
-
Corporate
- 5 years
- 1
- 75%+
-
Resident of United Kingdom
Managers
-
Individual
- 4 years
- 2
-
Resident of United Kingdom
-
Individual
- 5 years
-
Resident of United Kingdom
-
Individual
- 5 years
- 26
-
Resident of United Kingdom
Last reports
The latest confirmation statement submitted nine months ago.
Last news
-
Notification of Modern Pharma Limited as a person with significant control on 2024-04-12Download 2 pages pdf report
-
Cessation of Westbourne Pharmacy Limited as a person with significant control on 2024-04-12Download 1 page pdf report
-
Confirmation statement made on 2025-06-17 with no updatesDownload 3 pages pdf report
FAQ about Clarepharm Limited
Looking for leads in the UK?
Book a demo—see how CorpSignals can help you find UK leads.